SDHD gene

Mutations in the SDHD gene are uniquely associated with tumors on the left side of the body, particularly in the head and neck region. This is because SDHD is a mitochondrial gene inherited only from the mother. If a father carries the mutation, it is not passed to his children, and if a mother carries it, the resulting tumors tend to be left-sided. In contrast, mutations in other genes like SDHB are more commonly associated with right-sided tumors and a higher risk of malignancy. What specific symptoms should prompt a patient with a known SDHD mutation to seek immediate emergency care?::Patients should seek immediate emergency care if they experience sudden, severe headaches, palpitations, sweating, or high blood pressure, as these are classic signs of a pheochromocytoma crisis. Additionally, persistent abdominal pain, unexplained weight loss, or vomiting blood may indicate a gastrointestinal stromal tumor (GIST) or bleeding from a paraganglioma. Because these tumors can release large amounts of catecholamines, any sudden change in blood pressure or heart rate requires urgent medical evaluation to prevent life-threatening complications. Does having an SDHD mutation mean I will definitely develop cancer, and how is the risk managed?::No, having an SDHD mutation does not guarantee cancer development, but it significantly increases the lifetime risk of developing paragangliomas, pheochromocytomas, and GISTs. The condition is autosomal dominant, meaning one copy of the mutated gene is enough to increase risk, but a second "hit" (somatic mutation) is required for tumor formation. Management involves regular surveillance, typically including annual MRI scans of the head, neck, and abdomen, as well as blood and urine tests for catecholamines, to detect tumors early when they are most treatable. Can SDHD-related tumors be treated with surgery, and what are the long-term considerations?::Surgery is the primary treatment for most SDHD-related tumors, such as removing a paraganglioma or a GIST. However, because these patients have a genetic predisposition, they are at risk for developing new tumors in other locations over time. Therefore, long-term follow-up is critical. Additionally, if a pheochromocytoma is present, patients must be carefully managed with alpha-blockers before surgery to control blood pressure and prevent hypertensive crises during the procedure.